Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Exosomal GCC2 acts as a Promising Biomarker and Therapeutic Target for Lung Adenocarcinoma: a Multicenter Clinical TrialExosomal GCC2 acts as a Promising Biomarker and Therapeutic Target for Lung Adenocarcinoma: a Multicenter Clinical Trial
- Alternative Title
- Exosomal GCC2 acts as a Promising Biomarker and Therapeutic Target for Lung Adenocarcinoma: a Multicenter Clinical Trial
- Authors
- Hyun Koo Kim
- Issue Date
- 4-Nov-2022
- Publisher
- 대한흉부심장혈관외과학회
- Citation
- 2022 대한심장혈관흉부외과학회 제54차 추계학술대회
- Conference Name
- 2022 대한심장혈관흉부외과학회 제54차 추계학술대회
- Place
- KO
- Conference Date
- 2022-11-03
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, Hyun Koo
- Department of Biomedical Sciences